{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:09:18Z","timestamp":1791846558949,"version":"4.3.4"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ebiom.2024.105185","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T12:45:25Z","timestamp":1717764325000},"page":"105185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3694-6597","authenticated-orcid":false,"given":"Stefan","family":"Slamanig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-3987","authenticated-orcid":false,"given":"Lauren A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsoi Ying","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Dolange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Abdeljawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Kowdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moataz","family":"Noureddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Warang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-2741","authenticated-orcid":false,"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schotsaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2435-5047","authenticated-orcid":false,"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105185_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1126\/science.abl8487","article-title":"COVID-19 vaccine breakthrough infections","volume":"374","author":"Gupta","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105185_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41586-021-04085-y","article-title":"Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity","volume":"600","author":"Lucas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105185_bib4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105185_bib5","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A\u00a0bivalent omicron-containing booster vaccine against covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib6","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/s41591-022-02031-7","article-title":"Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2\/3 trial","volume":"28","author":"Chalkias","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S1473-3099(23)00295-5","article-title":"Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial","volume":"23","author":"Lee","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105185_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A\u00a0single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2024.105185_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm0829","article-title":"mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"374","author":"Goel","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105185_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","article-title":"SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses","volume":"596","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105185_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41385-022-00511-0","article-title":"Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection","volume":"15","author":"Sheikh-Mohamed","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib12","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A\u00a0single-dose intranasal Chad vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105185_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100230","article-title":"A\u00a0single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques","volume":"2","author":"Hassan","year":"2021","journal-title":"Cell Reports Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A\u00a0single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105185_bib17","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1038\/s41467-021-26178-y","article-title":"ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7","volume":"12","author":"Fischer","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105185_bib18","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026153118","article-title":"A\u00a0safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike","volume":"118","author":"Lu","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105185_bib19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A\u00a0live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci Bull"},{"issue":"27","key":"10.1016\/j.ebiom.2024.105185_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi5246","article-title":"Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine","volume":"7","author":"An","year":"2021","journal-title":"Sci Adv"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105185_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103219","article-title":"Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease","volume":"24","author":"Warner","year":"2021","journal-title":"iScience"},{"issue":"6622","key":"10.1016\/j.ebiom.2024.105185_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2024.105185_bib23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines - fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib24","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/423001","article-title":"Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years","volume":"39","author":"Belshe","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105185_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-2600(22)00087-X","article-title":"Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105185_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1473-3099(23)00350-X","article-title":"Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial","volume":"23","author":"Li","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105185_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1063679","article-title":"Preclinical evaluation of safety and immunogenicity of a primary series intranasal COVID-19 vaccine candidate (BBV154) and humoral immunogenicity evaluation of a heterologous prime-boost strategy with COVAXIN (BBV152)","volume":"13","author":"Sunagar","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105185_bib29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41590-024-01743-x","article-title":"Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection","volume":"25","author":"Ying","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103132","article-title":"Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate","volume":"62","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2024.105185_bib31","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/vaccines8040771","article-title":"A\u00a0Newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine","volume":"8","author":"Sun","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ebiom.2024.105185_bib32","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1038\/s41467-021-26499-y","article-title":"A\u00a0Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01538-22","article-title":"Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice","volume":"10","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ebiom.2024.105185_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101323","article-title":"Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: interim results of a randomised, placebo-controlled, phase 1 trial","volume":"45","author":"Pitisuttithum","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2024.105185_bib35","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.vaccine.2022.04.078","article-title":"Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: interim results of a randomized, placebo-controlled, phase 1\/2 trial in Vietnam","volume":"40","author":"Duc","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105185_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Le\u00f3n","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2024.105185_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2847","article-title":"An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination","volume":"15","author":"Carre\u00f1o","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00376-16","article-title":"Efficient and robust paramyxoviridae reverse genetics Systems","volume":"2","author":"Beaty","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.ebiom.2024.105185_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter","volume":"73","author":"Buchholz","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105185_bib40","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"issue":"80","key":"10.1016\/j.ebiom.2024.105185_bib41","first-page":"50830","article-title":"Rescue of recombinant Newcastle disease virus from cDNA","author":"Ayllon","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ebiom.2024.105185_bib42","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1038\/s41467-021-24909-9","article-title":"Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants","volume":"12","author":"Ikegame","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab Anim (NY)"},{"key":"10.1016\/j.ebiom.2024.105185_bib44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-022-00914-2","article-title":"Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding","volume":"7","author":"Lin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2024.105185_bib45","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2024.105185_bib46","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1038\/s41467-022-33068-4","article-title":"The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition","volume":"13","author":"Motozono","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib47","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cell.2021.01.050","article-title":"Maturation and persistence of the anti-SARS-CoV-2 memory B cell response","volume":"184","author":"Sokal","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105185_bib48","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","article-title":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","volume":"185","author":"R\u00f6ltgen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105185_bib49","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4049\/jimmunol.1502472","article-title":"Germinal center B cell and T follicular helper cell responses to viral vector and protein-in-adjuvant vaccines","volume":"197","author":"Wang","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4509","article-title":"Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2","volume":"6","author":"Israelow","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105185_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib53","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/s41467-020-16464-6","article-title":"Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow","volume":"11","author":"Riedel","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib54","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/eji.201343716","article-title":"Generation of memory B cells inside and outside germinal centers","volume":"44","author":"Takemori","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib55","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1084\/jem.20062571","article-title":"New markers for murine memory B cells that define mutated and unmutated subsets","volume":"204","author":"Anderson","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib56","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2007-11-123844","article-title":"The human spleen is a major reservoir for long-lived vaccinia virus\u2013specific memory B cells","volume":"111","author":"Mamani-Matsuda","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ebiom.2024.105185_bib57","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/eji.200939531","article-title":"Memory B cells: effectors of long-lived immune responses","volume":"39","author":"Tangye","year":"2009","journal-title":"Eur J Immunol"},{"issue":"7902","key":"10.1016\/j.ebiom.2024.105185_bib58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","article-title":"SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters","volume":"603","author":"Halfmann","year":"2022","journal-title":"Nature"},{"issue":"7902","key":"10.1016\/j.ebiom.2024.105185_bib59","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105185_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.923","article-title":"Antigenic imprinting in SARS-CoV-2","volume":"12","author":"Reincke","year":"2022","journal-title":"Clin Transl Med"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105185_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00118-0","article-title":"Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies","volume":"4","author":"Carre\u00f1o","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2024.105185_bib62","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41586-023-06025-4","article-title":"SARS-CoV-2 Omicron boosting induces de novo B cell response in humans","volume":"617","author":"Alsoussi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105185_bib63","first-page":"572","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc Am Philos Soc"},{"key":"10.1016\/j.ebiom.2024.105185_bib64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.1801149","article-title":"Original antigenic sin: how first exposure shapes lifelong anti\u2013influenza virus immune responses","volume":"202","author":"Zhang","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ebiom.2024.105185_bib66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-immunol-042617-053214","article-title":"Tissue-resident T cells and other resident leukocytes","volume":"37","author":"Masopust","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib67","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1084\/jem.20160938","article-title":"Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance","volume":"213","author":"Takamura","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib68","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.1800219","article-title":"A\u00a0prime-pull-amplify vaccination strategy to maximize induction of circulating and genital-resident intraepithelial CD8+ memory T cells","volume":"202","author":"\u00c7uburu","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib69","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1038\/s41467-021-27063-4","article-title":"Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization","volume":"12","author":"Lapuente","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105185_bib70","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.4049\/jimmunol.1201682","article-title":"Cutting edge: intravascular staining redefines lung CD8 T cell responses","volume":"189","author":"Anderson","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib71","article-title":"Pathogen-specific T cell polyfunctionality is a correlate of T cell efficacy and immune protection","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105185_bib72","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib73","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41385-018-0006-7","article-title":"Oral cholera vaccination promotes homing of IgA+ memory B cells to the large intestine and the respiratory tract article","volume":"11","author":"Van Splunter","year":"2018","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib75","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib76","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/JVI.78.6.2666-2673.2004","article-title":"Neutralizing antibodies and CD8\u00a0+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors","volume":"78","author":"Sumida","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105185_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi8635","article-title":"Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity","volume":"6","author":"Sanchez","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2024.105185_bib81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1056\/NEJMc2213948","article-title":"Immunogenicity of BA.5 bivalent mRNA vaccine boosters","volume":"388","author":"Collier","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105185_bib82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2213907","article-title":"Antibody response to Omicron BA.4\u2013BA.5 bivalent booster","volume":"388","author":"Wang","year":"2023","journal-title":"N\u00a0Engl J Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T17:52:24Z","timestamp":1726768344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424002202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":78,"alternative-id":["S2352396424002202"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105185","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105185"}}